Literature DB >> 12704172

Production of the siderophore 2,3-dihydroxybenzoic acid is required for wild-type growth of Brucella abortus in the presence of erythritol under low-iron conditions in vitro.

Bryan H Bellaire1, Philip H Elzer, Cynthia L Baldwin, R Martin Roop.   

Abstract

Production of the siderophore 2,3-dihyroxybenzoic acid (2,3-DHBA) is required for the wild-type virulence of Brucella abortus in cattle. A possible explanation for this requirement was uncovered when it was determined that a B. abortus dhbC mutant (BHB1) defective in 2,3-DHBA production displays marked growth restriction in comparison to its parent strain, B. abortus 2308, when cultured in the presence of erythritol under low-iron conditions. This phenotype is not displayed when these strains are cultured under low-iron conditions in the presence of other readily utilizable carbon and energy sources. The addition of either exogenous 2,3-DHBA or FeCl(3) relieves this growth defect, suggesting that the inability of the B. abortus dhbC mutant to display wild-type growth in the presence of erythritol under iron-limiting conditions is due to a defect in iron acquisition. Restoring 2,3-DHBA production to the B. abortus dhbC mutant by genetic complementation abolished the erythritol-specific growth defect exhibited by this strain in low-iron medium, verifying the relationship between 2,3-DHBA production and efficient growth in the presence of erythritol under low-iron conditions. The positive correlation between 2,3-DHBA production and growth in the presence of erythritol was further substantiated by the observation that the addition of erythritol to low-iron cultures of B. abortus 2308 stimulated the production of 2,3-DHBA by increasing the transcription of the dhbCEBA operon. Correspondingly, the level of exogenous iron needed to repress dhbCEBA expression in B. abortus 2308 was also greater when this strain was cultured in the presence of erythritol than that required when it was cultured in the presence of any of the other readily utilizable carbon and energy sources tested. The tissues of the bovine reproductive tract are rich in erythritol during the latter stages of pregnancy, and the ability to metabolize erythritol is thought to be important to the virulence of B. abortus in pregnant ruminants. Consequently, the experimental findings presented here offer a plausible explanation for the attenuation of the B. abortus 2,3-DHBA-deficient mutant BHB1 in pregnant ruminants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704172      PMCID: PMC153232          DOI: 10.1128/IAI.71.5.2927-2932.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Sugar metabolism by Brucellae.

Authors:  Richard C Essenberg; Rekha Seshadri; Karen Nelson; Ian Paulsen
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

2.  The siderophore 2,3-dihydroxybenzoic acid is not required for virulence of Brucella abortus in BALB/c mice.

Authors:  B H Bellaire; P H Elzer; C L Baldwin; R M Roop
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Erythritol catabolism by Brucella abortus.

Authors:  J F Sperry; D C Robertson
Journal:  J Bacteriol       Date:  1975-02       Impact factor: 3.490

4.  The defect in the metabolism of erythritol of the Brucella abortus B19 vaccine strain is unrelated with its attenuated virulence in mice.

Authors:  F J Sangari; M J Grilló; M P Jiménez De Bagüés; M I González-Carreró; J M García-Lobo; J M Blasco; J Agüero
Journal:  Vaccine       Date:  1998-10       Impact factor: 3.641

Review 5.  Microbial iron transport: iron acquisition by pathogenic microorganisms.

Authors:  B R Byers; J E Arceneaux
Journal:  Met Ions Biol Syst       Date:  1998

6.  The glucose catabolism of the genus Brucella. II. Cell-free studies with B. abortus (S-19).

Authors:  D C Robertson; W G McCullough
Journal:  Arch Biochem Biophys       Date:  1968-09-20       Impact factor: 4.013

7.  The glucose catabolism of the genus Brucella. I. Evaluation of pathways.

Authors:  D C Robertson; W G McCullough
Journal:  Arch Biochem Biophys       Date:  1968-09-20       Impact factor: 4.013

8.  Brucella abortus siderophore 2,3-dihydroxybenzoic acid (DHBA) facilitates intracellular survival of the bacteria.

Authors:  Michelle A Parent; Bryan H Bellaire; Erin A Murphy; R Martin Roop; Phillip H Elzer; Cynthia L Baldwin
Journal:  Microb Pathog       Date:  2002-05       Impact factor: 3.738

9.  Metabolic characterization of the genus Brucella. VI. Growth stimulation by i-erythritol compared with strain virulence for guinea pigs.

Authors:  M E Meyer
Journal:  J Bacteriol       Date:  1967-03       Impact factor: 3.490

10.  The chemical basis of the virulence of Brucella abortus. I. Isolation of Br. abortus from bovine foetal tissue.

Authors:  H SMITH; J KEPPIE; J H PEARCE; R FULLER; A E WILLIAMS
Journal:  Br J Exp Pathol       Date:  1961-12
View more
  18 in total

1.  Accumulation of isochorismate-derived 2,3-dihydroxybenzoic 3-O-beta-D-xyloside in arabidopsis resistance to pathogens and ageing of leaves.

Authors:  Michael Bartsch; Paweł Bednarek; Pedro D Vivancos; Bernd Schneider; Edda von Roepenack-Lahaye; Christine H Foyer; Erich Kombrink; Dierk Scheel; Jane E Parker
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Characterization of the organic hydroperoxide resistance system of Brucella abortus 2308.

Authors:  Clayton C Caswell; John E Baumgartner; Daniel W Martin; R Martin Roop
Journal:  J Bacteriol       Date:  2012-07-20       Impact factor: 3.490

3.  The iron-responsive regulator irr is required for wild-type expression of the gene encoding the heme transporter BhuA in Brucella abortus 2308.

Authors:  Eric S Anderson; James T Paulley; David A Martinson; Jennifer M Gaines; Kendra H Steele; R Martin Roop
Journal:  J Bacteriol       Date:  2011-07-29       Impact factor: 3.490

4.  Erythritol feeds the pentose phosphate pathway via three new isomerases leading to D-erythrose-4-phosphate in Brucella.

Authors:  Thibault Barbier; François Collard; Amaia Zúñiga-Ripa; Ignacio Moriyón; Thibault Godard; Judith Becker; Christoph Wittmann; Emile Van Schaftingen; Jean-Jacques Letesson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

5.  The bhuQ gene encodes a heme oxygenase that contributes to the ability of Brucella abortus 2308 to use heme as an iron source and is regulated by Irr.

Authors:  Jenifer F Ojeda; David A Martinson; Evan A Menscher; R Martin Roop
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

Review 6.  Metal acquisition and virulence in Brucella.

Authors:  R Martin Roop
Journal:  Anim Health Res Rev       Date:  2012-05-25       Impact factor: 2.615

7.  The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilization by Brucella melitensis 16M.

Authors:  Isabelle Danese; Valerie Haine; Rose-May Delrue; Anne Tibor; Pascal Lestrate; Olivier Stevaux; Pascal Mertens; Jean-Yves Paquet; Jacques Godfroid; Xavier De Bolle; Jean-Jacques Letesson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Erythritol triggers expression of virulence traits in Brucella melitensis.

Authors:  Erik Petersen; Gireesh Rajashekara; Neelima Sanakkayala; Linda Eskra; Jerome Harms; Gary Splitter
Journal:  Microbes Infect       Date:  2013-02-16       Impact factor: 2.700

Review 9.  Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.

Authors:  R Martin Roop; Jennifer M Gaines; Eric S Anderson; Clayton C Caswell; Daniel W Martin
Journal:  Med Microbiol Immunol       Date:  2009-09-22       Impact factor: 3.402

10.  Diverse genetic regulon of the virulence-associated transcriptional regulator MucR in Brucella abortus 2308.

Authors:  Clayton C Caswell; Ahmed E M Elhassanny; Emilie E Planchin; Christelle M Roux; Jenni N Weeks-Gorospe; Thomas A Ficht; Paul M Dunman; R Martin Roop
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.